The prognosis of patients with stage 111 nonsmall cell lung cancer was studied, with special attention to their biologic status prior to lung resection. The biologic status was estimated from the neutrophil /lymphocyte ratio in the peripheral blood, serum albumin level, and erythrocyte sedimentation
Importance of biologic status to the postoperative prognosis of patients with stage III nonsmall cell lung cancer
- Book ID
- 123536759
- Publisher
- Elsevier Science
- Year
- 1989
- Tongue
- English
- Weight
- 163 KB
- Volume
- 5
- Category
- Article
- ISSN
- 0169-5002
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract ## BACKGROUND. The objective of this study was to assess the value of combinedβmodality therapy in elderly patients by comparing the differences in outcome between patients who received radiotherapy (RT) alone and patients who received RT plus chemotherapy for stage III nonsmall cell l
## Abstract ## BACKGROUND: The objective of this study was to identify the factors associated with improved outcome after treatment for stage III nonsmall cell lung cancer (NSCLC). ## METHODS: A retrospective review of stage III NSCLC patients treated at who were treated at the DanaβFarber Cance
## Abstract Thirtyβfive patients with Stage I carcinoma of the lung were tested postoperatively to assess lymphoβproliferative responses. Depressed lymphocyte proliferation (LP) responses to alloantigen in the mixed leukocyte culture (MLC) as measured by the relative proliferation index (RPI) were
## Abstract ## BACKGROUND Elevated serum carcinoembryonic antigen (CEA) levels are sometimes attributable to the production of CEA by malignant cells, and in turn, the antigen itself can enhance the metastatic potential of malignant cells. The authors speculated that low serum CEA levels might be